Literature DB >> 26671978

Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.

Esther E Creemers1, Amira Bawazeer2, Alejandro P Ugalde2, Hanneke W M van Deutekom2, Ingeborg van der Made2, Nina E de Groot2, Michiel E Adriaens2, Stuart A Cook2, Connie R Bezzina2, Norbert Hubner2, Jolanda van der Velden2, Ran Elkon2, Reuven Agami2, Yigal M Pinto1.   

Abstract

RATIONALE: Alternative cleavage and polyadenylation (APA) of mRNA represents a layer of gene regulation that to date has remained unexplored in the heart. This phenomenon may be relevant, as the positioning of the poly(A) tail in mRNAs influences the length of the 3'-untranslated region (UTR), a critical determinant of gene expression.
OBJECTIVE: To investigate whether the 3'UTR length is regulated by APA in the human heart and whether this changes in the failing heart. METHODS AND
RESULTS: We used 3'end RNA sequencing (e3'-Seq) to directly measure global patterns of APA in healthy and failing human heart specimens. By monitoring polyadenylation profiles in these hearts, we identified disease-specific APA signatures in numerous genes. Interestingly, many of the genes with shortened 3'UTRs in heart failure were enriched for functional groups such as RNA binding, whereas genes with longer 3'UTRs were enriched for cytoskeletal organization and actin binding. RNA sequencing in a larger series of human hearts revealed that these APA candidates are often differentially expressed in failing hearts, with an inverse correlation between 3'UTR length and the level of gene expression. Protein levels of the APA regulator, poly(A)-binding protein nuclear-1 were substantially downregulated in failing hearts.
CONCLUSIONS: We provide genome-wide, high-resolution polyadenylation maps of the human heart and show that the 3'end formation of mRNA is dynamic in heart failure, suggesting that APA-mediated 3'UTR length modulation represents an additional layer of gene regulation in failing hearts.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathies; gene expression regulation; heart failure; humans; polyadenylation; untranslated regions

Mesh:

Substances:

Year:  2015        PMID: 26671978     DOI: 10.1161/CIRCRESAHA.115.307082

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

Review 1.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

2.  Bivariate Genome-Wide Association Scan Identifies 6 Novel Loci Associated With Lipid Levels and Coronary Artery Disease.

Authors:  Katherine M Siewert; Benjamin F Voight
Journal:  Circ Genom Precis Med       Date:  2018-12

3.  Star-PAP controlled alternative polyadenylation coupled poly(A) tail length regulates protein expression in hypertrophic heart.

Authors:  A P Sudheesh; Nimmy Mohan; Nimmy Francis; Rakesh S Laishram; Richard A Anderson
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

Review 4.  Alternative polyadenylation of mRNA precursors.

Authors:  Bin Tian; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-28       Impact factor: 94.444

Review 5.  Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype.

Authors:  Mayra de A Marques; Guilherme A P de Oliveira
Journal:  Front Physiol       Date:  2016-09-23       Impact factor: 4.566

Review 6.  Alternative Polyadenylation: Methods, Findings, and Impacts.

Authors:  Wei Chen; Qi Jia; Yifan Song; Haihui Fu; Gang Wei; Ting Ni
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-10-12       Impact factor: 7.691

Review 7.  Discovery of alternative polyadenylation dynamics from single cell types.

Authors:  Congting Ye; Juncheng Lin; Qingshun Q Li
Journal:  Comput Struct Biotechnol J       Date:  2020-04-20       Impact factor: 7.271

Review 8.  Emerging Roles of RNA 3'-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders.

Authors:  Jamie Nourse; Stefano Spada; Sven Danckwardt
Journal:  Biomolecules       Date:  2020-06-17

9.  Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function.

Authors:  Chris McDermott-Roe; Marion Leleu; Glenn C Rowe; Oleg Palygin; John D Bukowy; Judy Kuo; Monika Rech; Steffie Hermans-Beijnsberger; Sebastian Schaefer; Eleonora Adami; Esther E Creemers; Matthias Heinig; Blanche Schroen; Zoltan Arany; Enrico Petretto; Aron M Geurts
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

10.  Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.

Authors:  Zhuyi Xue; René L Warren; Ewan A Gibb; Daniel MacMillan; Johnathan Wong; Readman Chiu; S Austin Hammond; Chen Yang; Ka Ming Nip; Catherine A Ennis; Abigail Hahn; Sheila Reynolds; Inanc Birol
Journal:  BMC Genomics       Date:  2018-07-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.